ADMA Biologics
Happiness rating is 48 out of 100
2.1 out of 5 stars.
Write a review

About ADMA Biologics

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of Primary Immune Deficiency Disease (PIDD) and certain infectious diseases. ADMA's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche – 


Our superior commitment to patients is anchored to our core values:
We make human connection a priority in our products, our patients, and our people.
We take on the challenges others won't by embracing rare diseases and the underserved populations.
We are relentless in transforming groundbreaking science into meaningful action.
We are tireless in our pursuit of perfection because people's lives are in our hands.
Through our relentless commitment to improving people’s lives, we are changing the future with immunotechnology.

Our Growth

Our goal is to be a leader in developing and commercializing specialized, targeted, plasma-derived therapeutics to extend and enhance the lives of individuals who are naturally or medically immunocompromised.
As part of our ongoing commercialization efforts, we plan to hire a small, specialty sales force to market RI-002, if approved, to hospitals, physician offices/clinics, and other specialty treatment organizations. We anticipate staffing additional personnel for patient support, medical affairs, quality assurance, regulatory affairs, scientific affairs, reimbursement, inventory and logistics, human resources, financial and operational management. If and when we receive FDA approval, we may also use a network of national distributors to fulfill orders for RI-002 for use by healthcare professionals and hospitals.


Our Diversity Makes Us Stronger
The members of ADMA Biologics' management team come from different disciplines and professional backgrounds, we share a common passion and desire to drive goals that improve the lives of patients.

What We Do

ADMA Biologics is one of the few plasma fractionation facilities in the U.S. that develops and commercializes plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection.


We offer a highly competitive total compensation package with comprehensive, flexible benefits. After all, it’s our commitment to keeping our employees happy and healthy that drives our continued success as a pioneer in the biopharmaceutical industry. Included in our benefits are:
- Medical, dental, vision and life
- Pet insurance
- 401K plan with employer match and immediate vesting
- Company paid short term and long term disability insurance
- Tuition Assistance (after the first year)
- Paid time off (within the first year)
- Company paid holidays